Tuomas Heikkinen

10.3k citations

30 papers · 876 indexed · h-index 16

Co-authors: Heli Nevanlinna Kristiina Aittomäki Carl Blomqvist Päivi Heikkilä Ralf Bützow Pia Vahteristo Kirsimari Aaltonen Jiřina Bártková
Topics: DNA Repair Mechanisms (7 papers)BRCA gene mutations in cancer (6 papers)Uterine Myomas and Treatments (6 papers)
Cited by: Obstetrics and Gynecology Cancer Research Reproductive Medicine
Journals: PLoS ONE The Journal of Clinical Endocrinology & Metabolism Cancer Research
Partner nations: Finland Sweden United States

In The Last Decade

Tuomas Heikkinen

28 papers receiving 862 citations

Peers

Countries citing papers authored by Tuomas Heikkinen

Since Specialization

Citations

This map shows the geographic impact of Tuomas Heikkinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuomas Heikkinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuomas Heikkinen more than expected).

Fields of papers citing papers by Tuomas Heikkinen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tuomas Heikkinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuomas Heikkinen. The network helps show where Tuomas Heikkinen may publish in the future.

Co-authorship network of co-authors of Tuomas Heikkinen

This figure shows the co-authorship network connecting the top 25 collaborators of Tuomas Heikkinen. A scholar is included among the top collaborators of Tuomas Heikkinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tuomas Heikkinen. Tuomas Heikkinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A novel uterine leiomyoma subtype exhibits NRF2 activation and mutations in genes associated with neddylation of the Cullin 3-RING E3 ligase 2022 ·Oncogenesis ·Miika Mehine,(unknown),(unknown),Jouni Härkönen,(unknown),Tuomas Heikkinen,(unknown),P. Pakarinen,Päivi Härkki,Annukka Pasanen,Anna–Liisa Levonen,Ralf Bützow,Pia Vahteristo	12
2	Women’s Reasons to Seek Bariatric Surgery and Their Expectations on the Surgery Outcome — a Multicenter Study from Five European Countries 2022 ·Obesity Surgery ·(unknown),Wouter te Riele,Lars Fischer,(unknown),(unknown),Tuomas Heikkinen,Rune Sandbu,Anne Juuti,Stephanie E. Bonn	4
3	Exome Sequencing of Uterine Leiomyosarcomas Identifies Frequent Mutations in TP53, ATRX, and MED12 2016 ·PLoS Genetics ·Netta Mäkinen,Mervi Aavikko,Tuomas Heikkinen,Minna Taipale,Jussi Taipale,Riitta Koivisto-Korander,Ralf Bützow,Pia Vahteristo	81
4	MED12 mutations and FH inactivation are mutually exclusive in uterine leiomyomas 2016 ·British Journal of Cancer ·Kati Kämpjärvi,Netta Mäkinen,Miika Mehine,(unknown),Outi Uimari,Esa Pitkänen,Hanna-Riikka Heinonen,Tuomas Heikkinen,Jaana Tolvanen,Anne Ahtikoski,Norma Frizzell,Nanna Sarvilinna,Jari Sjöberg,Ralf Bützow,Lauri A. Aaltonen,Pia Vahteristo	36
5	Evaluation of the RHINO gene for breast cancer predisposition in Finnish breast cancer families 2014 ·Breast Cancer Research and Treatment ·Tuomas Heikkinen,Sofia Khan,(unknown),(unknown),Johanna Schleutker,Anne Kallioniemi,Carl Blomqvist,Kristiina Aittomäki,Heli Nevanlinna	0
6	Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemia 2014 ·Oncotarget ·Kati Kämpjärvi,Tiina M. Järvinen,Tuomas Heikkinen,Amy S. Ruppert,Leigha Senter,(unknown),Olli Dufva,Mika Kontro,Laura Z. Rassenti,Erin Hertlein,Thomas J. Kipps,Kimmo Porkka,John C. Byrd,Albert de la Chapelle,Pia Vahteristo	35
7	Overabundant FANCD2, alone and combined with NQO1, is a sensitive marker of adverse prognosis in breast cancer 2013 ·Annals of Oncology ·Rainer Fagerholm,Kam Sprott,Tuomas Heikkinen,Jiřina Bártková,Päivi Heikkilä,Kristiina Aittomäki,Jiří Bártek,David T. Weaver,Carl Blomqvist,Heli Nevanlinna	27
8	Polymorphisms in oxidative stress-related genes and mortality in breast cancer patients – Potential differential effects by radiotherapy? 2013 ·The Breast ·Petra Seibold,Per Hall,Nils Schoof,Heli Nevanlinna,Tuomas Heikkinen,Axel Benner,Jianjun Liu,Peter Schmezer,Odilia Popanda,Dieter Flesch‐Janys,Jenny Chang‐Claude	23
9	Eukaryotic translation initiation factor 4E (eIF4E) expression is associated with breast cancer tumor phenotype and predicts survival after anthracycline chemotherapy treatment 2013 ·Breast Cancer Research and Treatment ·Tuomas Heikkinen,(unknown),Rainer Fagerholm,Sofia Khan,Kristiina Aittomäki,Päivi Heikkilä,Carl Blomqvist,Olli Carpén,Heli Nevanlinna	27
10	MiR-34a Expression Has an Effect for Lower Risk of Metastasis and Associates with Expression Patterns Predicting Clinical Outcome in Breast Cancer 2011 ·PLoS ONE ·(unknown),Dario Greco,Tuomas Heikkinen,Sippy Kaur,Jiřina Bártková,(unknown),Kristiina Aittomäki,Päivi Heikkilä,Jiří Bártek,Carl Blomqvist,Ralf Bützow,Heli Nevanlinna	67
11	Variants on the promoter region of PTEN affect breast cancer progression and patient survival 2011 ·Breast Cancer Research ·Tuomas Heikkinen,Dario Greco,Liisa M. Pelttari,Johanna Tommiska,Pia Vahteristo,Päivi Heikkilä,Carl Blomqvist,Kristiina Aittomäki,Heli Nevanlinna	36
12	RAD51C is a susceptibility gene for ovarian cancer 2011 ·Human Molecular Genetics ·Liisa M. Pelttari,Tuomas Heikkinen,Deborah J. Thompson,Anne Kallioniemi,Johanna Schleutker,Kaija Holli,Carl Blomqvist,Kristiina Aittomäki,Ralf Bützow,Heli Nevanlinna	99
13	Utilization of fluorescence in situ hybridization with cytokeratin discriminators in TOP2A assessment of chemotherapy-treated patients with breast cancer 2011 ·Human Pathology ·William E. Pierceall,Kam Sprott,Tuomas Heikkinen,Päivi Heikkilä,(unknown),Kristiina Aittomäki,Mohammed Al-Adhami,(unknown),(unknown),Jeffery L. Kutok,Jiřina Bártková,Jiří Bártek,Heli Nevanlinna,David T. Weaver,Carl Blomqvist	2
14	Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer 2011 ·Breast Cancer Research ·Yuqing Li,Yi Li,Sara Wedrén,Guoliang Li,Tze Howe Charn,Kartiki V. Desai,Carine Bonnard,Kamila Czene,Keith Humphreys,Hatef Darabi,Kristjana Einarsdóttir,Tuomas Heikkinen,Kristiina Aittomäki,Carl Blomqvist,Kee Seng Chia,Heli Nevanlinna,Per Hall,Edison T. Liu,Jianjun Liu	14
15	Multi-Variant Pathway Association Analysis Reveals the Importance of Genetic Determinants of Estrogen Metabolism in Breast and Endometrial Cancer Susceptibility 2010 ·PLoS Genetics ·Yen Ling Low,Yuqing Li,Keith Humphreys,Anbupalam Thalamuthu,Yi Li,Hatef Darabi,Sara Wedrén,Carine Bonnard,Kamila Czene,Mark M. Iles,Tuomas Heikkinen,Kristiina Aittomäki,Carl Blomqvist,Heli Nevanlinna,Per Hall,Edison T. Liu,Jianjun Liu	35
16	Glycodelin expression associates with differential tumour phenotype and outcome in sporadic and familial non-BRCA1/2 breast cancer patients 2010 ·Breast Cancer Research and Treatment ·Laura Hautala,Dario Greco,Riitta Koistinen,Tuomas Heikkinen,Päivi Heikkilä,Kristiina Aittomäki,Carl Blomqvist,Hannu Koistinen,Heli Nevanlinna	16
17	Genome-wide search for breast cancer linkage in large Icelandic non-BRCA1/2 families 2010 ·Breast Cancer Research ·Aðalgeir Arason,Haukur Gunnarsson,Guðrún Jóhannesdóttir,Kristján Jónasson,Pär‐Ola Bendahl,Elizabeth M. Gillanders,Bjarni A. Agnarsson,Göran Jönsson,Katri Pylkäs,Aki Mustonen,Tuomas Heikkinen,Kristiina Aittomäki,Carl Blomqvist,Beatrice Melin,Oskar T. Johannsson,Pål Møller,Robert Winqvist,Heli Nevanlinna,Åke Borg,Rósa B. Barkardóttir	13
18	The Breast Cancer Susceptibility Mutation PALB2 1592delT Is Associated with an Aggressive Tumor Phenotype 2009 ·Clinical Cancer Research ·Tuomas Heikkinen,(unknown),Kirsimari Aaltonen,Roger L. Milne,Päivi Heikkilä,Kristiina Aittomäki,Carl Blomqvist,Heli Nevanlinna	94
19	Aberrations of the MRE11–RAD50–NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer‐predisposing gene 2008 ·Molecular Oncology ·Jiřina Bártková,Johanna Tommiska,(unknown),Kirsimari Aaltonen,Anitta Tamminen,Tuomas Heikkinen,Martin Mistrík,Kristiina Aittomäki,Carl Blomqvist,Päivi Heikkilä,(unknown),Heli Nevanlinna,Jiří Bártek	126
20	BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition 2005 ·European Journal of Human Genetics ·Pia Vahteristo,Kirsi Syrjäkoski,Tuomas Heikkinen,Hannaleena Eerola,Kristiina Aittomäki,Karl von Smitten,Kaija Holli,Carl Blomqvist,Olli Kallioniemi,Heli Nevanlinna	32

About Tuomas Heikkinen

Tuomas Heikkinen is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Cancer Research, having authored 30 papers that have together received 876 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (7 papers), BRCA gene mutations in cancer (6 papers) and Uterine Myomas and Treatments (6 papers). The work is most often cited by research in Obstetrics and Gynecology (135 citations), Cancer Research (239 citations) and Reproductive Medicine (118 citations). Tuomas Heikkinen has collaborated with scholars based in Finland, Sweden and United States. Frequent co-authors include Heli Nevanlinna, Kristiina Aittomäki, Carl Blomqvist, Päivi Heikkilä, Ralf Bützow, Pia Vahteristo, Kirsimari Aaltonen, Jiřina Bártková, Jiří Bártek and Liisa M. Pelttari. Their work appears in journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact